Risk Factors of Hypertensive Urgencies (OSADA)

This study has been completed.
Sponsor:
Collaborator:
KRKA
Information provided by:
Russian Cardiology Research and Production Center
ClinicalTrials.gov Identifier:
NCT00421239
First received: January 8, 2007
Last updated: December 8, 2008
Last verified: December 2008
  Purpose

The purpose of this study is to determine whether frequent hypertensive urgencies increase the risk of cardiovascular events in patients with arterial hypertension.


Condition
Hypertensive Urgency

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Retrospective Study of Hypertensive Urgencies in Patients With Arterial Hypertension

Resource links provided by NLM:


Further study details as provided by Russian Cardiology Research and Production Center:

Enrollment: 1200
Study Start Date: January 2007
Study Completion Date: December 2008

Detailed Description:

The spectrum of disorders associated with arterial hypertension (AH) encompasses chronic uncomplicated hypertension and the hypertensive crises, including hypertensive urgences and emergencies. Hypertensive crises accounted for more than 25% of all patient visits to a medical section of an emergency department, with hypertensive urgences (HU) accounting for two-third of these cases. Hypertensive crises, without prompt treatment, are often associated with morbidity and mortality. We propose to conduct a population-based case-control study of HU in areas of the Russian Federation. We will include about thirty study centers and one data coordinating center and will recruit study participants over a period of one years. We plan to conduct in-person interviews with 1,500 cases and 1,500 controls to elicit information on demographic background and history of exposures. We intend to test about 20-25 risk factors of HU thus calculated target number of subject is 3000 pts. We`re going to get access to hospital lists in each study center. From the database we`ll select patients with AH and recruit every third participant who came to hospital or/and policlinic. Every selected participant will be asked to respond to some questions by phone and be divided into two groups. Participants who have HU two weeks before the call will be questioned about level of arterial pressure and treatment during HU. Participants with often HU (every week or more) will be included into first group (prevalent cases, group A). Participants with seldom HU (every month or less) will be included into second group (controls, group B). Cases and controls will be selected from the same population of AH patients. Questionnaire contains information about age, gender, tobacco use, data about HU (frequency, treatment and its complications), antihypertensive and concomitant treatment, level of blood pressure, regularity of taking antihypertensive drugs, associated clinical conditions (cerebrovascular disease, heart disease, renal disease, peripheral vascular disease), PCI, CABG, if it be possible we intend to collect information of factors influencing prognosis (fasting plasma glucose, dyslipidaemia, serum creatinine, serum uric acid, left ventricular hypertrophy).

  Eligibility

Ages Eligible for Study:   18 Years to 79 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Participants will be selected from hospital/policlinic database by random telephone dialing to every third patient who are diagnosed with arterial hypertension (SBP/DBP>140/90 Hg or taking antihypertensive drugs)

Criteria

Inclusion Criteria:

  • Cases: every third patient from hospital/policlinic database who are diagnosed with arterial hypertension (SBP/DBP>140/90 Hg or taking anti hypertensive drugs) and with frequent (weekly or daily) hypertensive urgencies (SBP/DBP≥180/110 Hg) will be potentially eligible for the study.
  • Controls will be selected from the same population of participants by random telephone dialing to every third patient with arterial hypertension (SBP/DBP>140/90 Hg or taking anti hypertensive drugs) and with seldom (monthly, several times in the year or never) hypertensive urgencies.

Exclusion Criteria:

  • Hypertensive emergency
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00421239

Locations
Russian Federation
Russian Cardiology Research and Production Center
Moscow, Russian Federation
Sponsors and Collaborators
Russian Cardiology Research and Production Center
KRKA
Investigators
Study Chair: Evgeniy I Chazov, MD Russian Cardiology Research and Production Center
  More Information

No publications provided

Responsible Party: VNOK, Society of Cardiology of the Russian Federation
ClinicalTrials.gov Identifier: NCT00421239     History of Changes
Other Study ID Numbers: NCT00421239
Study First Received: January 8, 2007
Last Updated: December 8, 2008
Health Authority: Russia: Ministry of Health of the Russian Federation

Keywords provided by Russian Cardiology Research and Production Center:
hypertensive urgency
arterial hypertension

Additional relevant MeSH terms:
Hypertension
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on September 16, 2014